Hoth Therapeutics (HOTH) shares were down 3.1% in recent Monday trading after the company announced a $2.7 million at-the-market equity offering program in a late Friday filing with the US Securities and Exchange Commission.
The company said it may sell common shares under the program, with H.C. Wainwright as the sales manager.
Price: 0.89, Change: -0.03, Percent Change: -3.05
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments